| Methods for identification and confirmation of targeted subgroups in clinical trials: a systematic review T Ondra, A Dmitrienko, T Friede, A Graf, F Miller, N Stallard, M Posch Journal of biopharmaceutical statistics 26 (1), 99-119, 2016 | 83 | 2016 |
| A simulation study to compare new adaptive dose–ranging designs V Dragalin, B Bornkamp, F Bretz, F Miller, SK Padmanabhan, N Patel, ... Statistics in Biopharmaceutical Research 2 (4), 487-512, 2010 | 69 | 2010 |
| Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients J Peuskens, J Trivedi, S Malyarov, M Brecher, O Svensson, F Miller, ... Psychiatry (Edgmont) 4 (11), 34, 2007 | 69 | 2007 |
| A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or … JW Newcomer, RE Ratner, JW Eriksson, R Emsley, D Meulien, F Miller, ... Journal of Clinical Psychiatry; Journal of Clinical Psychiatry, 2009 | 68 | 2009 |
| Optimal designs for estimating the interesting part of a dose-effect curve F Miller, O Guilbaud, H Dette Journal of Biopharmaceutical Statistics 17 (6), 1097-1115, 2007 | 68 | 2007 |
| Psychometric evaluation of ADAS‐C og and NTB for measuring drug response A Karin, K Hannesdottir, J Jaeger, P Annas, M Segerdahl, P Karlsson, ... Acta Neurologica Scandinavica 129 (2), 114-122, 2014 | 44 | 2014 |
| Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis F Miller, M Björnsson, O Svensson, R Karlsten Contemporary clinical trials 37 (2), 189-199, 2014 | 40 | 2014 |
| Variance estimation in clinical studies with interim sample size reestimation F Miller Biometrics 61 (2), 355-361, 2005 | 36 | 2005 |
| Adaptive and model-based dose-ranging trials: quantitative evaluation and recommendations. White paper of the PhRMA working group on adaptive dose-ranging studies J Pinheiro, F Sax, Z Antonijevic, B Bornkamp, F Bretz, C Chuang-Stein, ... Statistics in Biopharmaceutical Research 2 (4), 435-454, 2010 | 35 | 2010 |
| Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia HJ Möller, S Johnson, T Mateva, M Brecher, O Svensson, F Miller, ... International clinical psychopharmacology 23 (2), 95, 2008 | 32 | 2008 |
| Adaptive two-stage test procedures to find the best treatment in clinical trials W Bischoff, F Miller Biometrika 92 (1), 197-212, 2005 | 32 | 2005 |
| Asymptotically optimal tests and optimal designs for testing the mean in regression models with applications to change-point problems W Bischoff, F Miller Annals of the Institute of Statistical Mathematics 52 (4), 658-679, 2000 | 31 | 2000 |
| Exact asymptotics for boundary crossings of the Brownian bridge with trend with application to the Kolmogorov test W Bischoff, E Hashorva, J Hüsler, F Miller Annals of the Institute of Statistical Mathematics 55 (4), 849-864, 2003 | 27 | 2003 |
| Asymptotics of a boundary crossing probability of a Brownian bridge with general trend W Bischoff, F Miller, E Hashorva, J Hüsler Methodology and Computing in Applied Probability 5 (3), 271-287, 2003 | 27 | 2003 |
| Determination of the optimal sample size for a clinical trial accounting for the population size N Stallard, F Miller, S Day, SW Hee, J Madan, S Zohar, M Posch Biometrical Journal 59 (4), 609-625, 2017 | 26 | 2017 |
| Optimal designs which are efficient for lack of fit tests W Bischoff, F Miller Annals of statistics 34 (4), 2015-2025, 2006 | 24 | 2006 |
| Decision-theoretic designs for small trials and pilot studies: a review SW Hee, T Hamborg, S Day, J Madan, F Miller, M Posch, S Zohar, ... Statistical methods in medical research 25 (3), 1022-1038, 2016 | 21 | 2016 |
| Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials. gov SW Hee, A Willis, CT Smith, S Day, F Miller, J Madan, M Posch, S Zohar, ... Orphanet journal of rare diseases 12 (1), 1-20, 2017 | 20 | 2017 |
| A note on change point estimation in dose–response trials T Friede, F Miller, W Bischoff, M Kieser Computational statistics & data analysis 37 (2), 219-232, 2001 | 20 | 2001 |
| Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo … J Peuskens, JK Trivedi, M Brecher, F Miller International clinical psychopharmacology 25 (3), 183, 2010 | 19 | 2010 |
wolfgang bischoffProfessor for Mathematics-Statistics, Catholic University Eichstätt-IngolstadtVerified email at ku.de
